Relating to a cancer clinical trial participation program.

SB 1357 establishes a program to reimburse cancer clinical trial participants for transportation, lodging, childcare, and other costs that prevent low-income individuals from joining trials. It specifically clarifies that reimbursing these "ancillary costs" is not an illegal "inducement" (as confirmed by the FDA), addressing a barrier identified in a 2015 study showing households earning under $50,000 were 30% less likely to participate. The program requires reimbursement based on financial need (prioritizing those at or below 700% of the federal poverty level) and collaboration with healthcare providers to notify prospective participants. This directly affects eligible cancer patients and aims to increase diversity in clinical trial participation by removing financial barriers.